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The bacterial plant pathogen Pseudomonas syringae depends on a type III protein secretion system and the
effector proteins that it translocates into plant cells to cause disease and to elicit the defense-associated
hypersensitive response on resistant plants. The availability of the P. syringae pv. tomato DC3000 genome
sequence has resulted in the identification of many novel effectors. We identified the hopPtoV effector gene on
the basis of its location next to a candidate type III chaperone (TTC) gene, shcV, and within a pathogenicity
island in the DC3000 chromosome. A DC3000 mutant lacking ShcV was unable to secrete detectable amounts
of HopPtoV into culture supernatants or translocate HopPtoV into plant cells, based on an assay that tested
whether HopPtoV-AvrRpt2 fusions were delivered into plant cells. Coimmunoprecipitation and Saccharomyces
cerevisiae two-hybrid experiments showed that ShcV and HopPtoV interact directly with each other. The ShcV
binding site was delimited to an N-terminal region of HopPtoV between amino acids 76 and 125 of the
391-residue full-length protein. Our results demonstrate that ShcV is a TTC for the HopPtoV effector. DC3000
overexpressing ShcV and HopPtoV and DC3000 mutants lacking either HopPtoV or both ShcV and HopPtoV
were not significantly impaired in disease symptoms or bacterial multiplication in planta, suggesting that
HopPtoV plays a subtle role in pathogenesis or that other effectors effectively mask the contribution of
HopPtoV in plant pathogenesis.
Pseudomonas syringae causes a variety of diseases on many
different susceptible plant species, generally producing chlo-
rotic and necrotic lesions on leaves or fruits (4, 43). Resistant
plants respond to a high level of P. syringae inoculum by pro-
ducing a defense-associated programmed cell death known as
the hypersensitive response. The ability of P. syringae both to
cause disease and to elicit a hypersensitive response are de-
pendent on the type III protein secretion system (TTSS) en-
coded by the hrp and hrc genes (5). The hrp and hrc genes are
contained within the Hrp pathogenicity island, and the flanking
regions are rich in genes that encode TTSS substrates (3).
TTSS substrates belong to two broad classes of type III-se-
creted proteins: effectors, which are translocated into plant
cells, and extracellular accessory proteins, which aid in the
translocation of effectors.
P. syringae TTSS effectors are generally named Avr (for
avirulence), Vir (for virulence), or Hop (for Hrp-dependent
outer protein) proteins, based on how they were originally
identified (5, 73). The completed genome sequencing of P.
syringae pv. tomato DC3000 has greatly facilitated the identi-
fication of effector genes in DC3000 (21, 32, 37, 39, 61, 79). The
majority of P. syringae TTSS substrates have common charac-
teristics in their N-terminal regions, including a high serine
content, a leucine, isoleucine, or valine at residue 3 or 4, and
the absence of aspartate or glutamate within the first 12 amino
acids (21, 37). The roles that these effectors play inside plant
cells remain largely unknown. However, several have recently
been shown to suppress innate plant immunity (1, 6, 15, 27, 41,
48, 57).
TTSSs are found in many plant, animal, and insect patho-
gens and other eukaryote-associated gram-negative bacteria
(22, 24, 34, 45). Many of the TTSS substrates from animal
pathogens utilize customized type III chaperones (TTCs) to
assist in their secretion (29, 60). These proteins bind to
specific TTSS substrates often preventing association with
other proteins and/or aggregation. They have also recently
been implicated in affecting the order of secretion of effec-
tors from TTSS-containing bacteria (13, 69). With the ex-
ception of clear homologs, generally TTCs do not show
sequence similarity with each other. However, they have
several general characteristics: they tend to be small pro-
teins (ca. 15 kDa in mass), possess acidic isoelectric points
(pI  6), and have an amphipathic region in their C termini,
and the gene that encodes the TTC is usually next to its
cognate effector gene (75). Moreover, the crystal structures
of several TTCs have been determined, and their three-
dimensional configurations are similar (10, 11, 28, 56, 68).
Based on the crystal structure of TTC-effector pairs, the
TTC binds to the effector so that the bound region of the
effector is in a nonglobular state (11, 68). Maintaining an
effector in a nonglobular state may make the effector com-
petent for type III secretion (67).
Bacterial plant pathogen TTSSs also utilize TTCs (35, 72).
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The first TTC identified in a bacterial plant pathogen was the
P. syringae ShcA protein (for specific Hop chaperone), which
assists in the type III secretion of the HopPsyA effector (72).
This report also identified several other candidate P. syringae
TTC genes flanking effector genes whose nucleotide sequences
were deposited in the databases (72). Recently, one of these
candidate chaperones, ShcM, was confirmed to function as a
TTC for the HopPtoM effector (8). Both ShcA and ShcM were
shown to bind to their cognate effectors (8, 72). The binding
site of ShcA was within the amino-terminal 166 amino acids of
HopPsyA, similar to the binding site location of TTCs in ani-
mal pathogens, whereas the binding site of ShcM was localized
between amino acids 100 and 400 of the 732-amino-acid-long
HopPtoM (8, 72).
Here we report a novel TTC-effector pair, ShcV and HopP-
toV, from P. syringae pv. tomato DC3000. We show that the
HopPtoV effector is secreted in culture and translocated via
the TTSS into plant cells in a manner dependent on ShcV.
Moreover, based on yeast two-hybrid analysis, we show that
ShcV binds to a site within the amino-terminal third of HopP-
toV. Collectively, these data demonstrate that HopPtoV is a
type III effector and that the ShcV TTC facilitates its secretion
via the DC3000 TTSS.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and
plasmids used are listed in Table 1. Escherichia coli strains were grown routinely
in LM (40) or Terrific broth (64) at 37°C. P. syringae strains were grown in King’s
B broth at 28°C (51). For type III secretion assays, P. syringae pv. tomato DC3000
strains were grown in hrp-inducing fructose medium at 22°C (46). Antibiotics
were used at the following concentrations: ampicillin, 100 g ml1; chloram-
phenicol, 20 g ml1; gentamicin, 10 g ml1; kanamycin, 50 g ml1; rifampin,
100 g ml1; spectinomycin, 50 g ml1; and tetracycline, 20 g ml1.
General DNA manipulations. For standard molecular biological manipula-
tions, well-described protocols were used (65). Restriction enzymes, T4 ligase,
and DNA polymerase were all purchased from New England Biolabs (Beverly,
Mass.). The thermostable DNA polymerase used in PCRs was Pfu polymerase
(Stratagene, La Jolla, Calif.). Oligonucleotide primers were ordered from In-
vitrogen (Grand Island, N.Y.) and Integrated DNA Technologies (Coralville,
Iowa). Information on the primers used in PCRs is provided in Table 2. The
standard cycling conditions used for PCRs were 2 min at 94°C; 30 cycles of 1 min
at 94°C, 1 min at 50°C, and 1 min at 72°C; and 10 min at 72°C. Plasmids were
introduced into Pseudomonas strains by electroporation. DNA sequence analysis
was performed with Lasergene software (DNAstar Inc., Madison, Wis.). Data-
base searches were done with BLASTN, BLASTP, BLASTX (http://www.ncbi
.nlm.nih.gov/BLAST/index.html), and 3D-PSSM (http://www.sbg.bio.ic.ac.uk/
3dpssm/).
Type III protein secretion assays. To clone shcV and hopPtoV into pML123
(53), we used primer P409, which contained the ribosome-binding site of shcV,
and P413, which annealed to the 3 end of hopPtoV and added a nucleotide
sequence encoding the hemagglutinin (HA) epitope. The resulting construct was
named pLN517. Primers P412, which contained the ribosome-binding site of
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Characteristic(s) Reference or source
E. coli DH5 supE44 lacU169(	80lacZM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Nalr 40; Life Technologies
P. fluorescens 55 Nalr 44
P. syringae pv. phaseolicola
NPS3121
Wild type; Rpr 49
P. syringae pv. tomato
DC3000 Wild type; Rpr 23
DC3000 hrcC Lacks hrcC, secretion-deficient mutant, Rpr Cmr 78
UNL120 DC3000 mutant containing a polar insertion in shcV, Rpr Spr This work
UNL125 DC3000 mutant containing an insertion mutation in hopPtoV, Rpr Spr This work
Plasmids
pCPP2318 pCPP30 derivative carrying blaM lacking signal peptide sequences, Tcr 20
pEG202 Yeast two-hybrid vector, creates fusion to LexA DNA binding domain, Apr 36
pHIR11 pLAFR3 derivative carrying P. snyringae pv. syringae 61 hrp/hrc cluster, Tcr 44
pJG4-5 Yeast two-hybrid vector, creates fusion to B42 activation domain, Apr 36
pKnockout-
 Vector used to make Campbell insertion mutations, Spr 76
pLN30 pKnockout-
 derivative for interruption of shcV, Spr This work
pLN31 pKnockout-
 derivative for interruption of hopPtoV, Spr This work
pLN127 pML123 derivative carrying hopPtoV with an HA tag, Gmr This work
pLN517 pML123 derivative carrying shcV and hopPtoV, Gmr This work
pLN290 pBBR1-MCS5 derivative containing avrRpt2 lacking N-terminal 40 residues and allowing
fusion of protein of interest at SpeI site, Gmr
This work
pLN679 pEG202 derivative carrying hopPtoV, Apr This work
pLN680 pJG4-5 derivative carrying shcV, Apr This work
pLN681 pJG4-5 derivative carrying hopPtoV, Apr This work
pLN688 pQE30 derivative carrying shcV, Apr This work
pLN702 pLN290 derivative carrying hopPtoV, Gmr This work
pLN703 pLN290 derivative carrying shcV and hopPtoV, Gmr This work
pLN709 pEG202 derivative carrying hopPtoV fragment corresponding to HopPtoV1–194, Ap
r This work
pLN710 pEG202 derivative carrying hopPtoV fragment corresponding to HopPtoV195–391, Ap
r This work
pLN728 pEG202 derivative carrying hopPtoV fragment corresponding to HopPtoV1–97, Ap
r This work
pLN730 pEG202 derivative carrying hopPtoV fragment corresponding to HopPtoV98–194, Ap
r This work
pLN739 pEG202 derivative carrying hopPtoV fragment corresponding to HopPtoV76–125, Ap
r This work
pLN765 pEG202 derivative carrying hopPtoV fragment corresponding to HopPtoV51–150, Ap
r This work
pML123 Broad-host-range cloning vector, Gmr 53
pQE30 Expression vector for affinity purification, IPTG inducible, N-terminal six-His tag, Apr Qiagen
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hopPtoV, and P413 were used to clone hopPtoV into pML123, resulting in
pLN127.
Type III protein secretion assays were performed on DC3000 cultures as
previously described (61, 71). In brief, DC3000 strains were grown in hrp-induc-
ing fructose medium at 22°C for 4 to 6 h. The cell-bound proteins -lactamase
(encoded by pCPP2318) and neomycin phosphotransferase II (NptII; encoded by
pML122) were used as indicators of nonspecific lysis. Cultures were separated
into cell-bound and supernatant fractions by centrifugation, and total protein
present in the supernatant fraction was precipitated with 12.5% trichloroacetic
acid. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) by standard procedures (64), transferred to poly-
vinylidene difluoride membranes, and immunoblotted with anti-HA (Roche Di-
agnostics Corp., Indianapolis, Ind.), anti-NPTII (Cortex Biochem, San Leandro,
Calif.), or anti--lactamase (Chemicon International, Temecula, Calif.) primary
antibodies. Anti--lactamase and anti-NPTII primary antibodies were recog-
nized with goat anti-rabbit immunoglobulin G-alkaline phosphatase conjugate
(Sigma Chemical Co., St. Louis, Mo.), and anti-HA primary antibodies were
recognized with goat anti-rat immunoglobulin G-alkaline phosphatase conjugate
(Sigma Chemical Co.). Membrane-bound secondary antibodies were visualized
with the Western Star chemiluminescence detection system (Applied Biosys-
tems, Foster City, Calif.) on X-ray film.
AvrRpt2 translocation assays. To determine if HopPtoV was translocated into
plant cells, we used the AvrRpt2 translocation assay (38, 59). avrRpt2, which
lacked 5 nucleotides corresponding to the amino-terminal 40 amino acids of
AvrRpt2, was PCR cloned with primers P516 and P511 and pAVRRPT2-600
(47) as a template. This fragment was cloned into pBBR1MCS-5 (52) with SpeI
and XbaI restriction sites, generating pLN290. hopPtoV was PCR cloned into
pLN290 with primers P412 and P1043, producing pLN702. A DNA fragment
containing shcV and hopPtoV was amplified with PCR with primers P578 and
P1043 and cloned into pLN290, resulting in construct pLN703. These constructs
were electroporated into P. syringae pv. phaseolicola NPS3121 and infiltrated
into Arabidopsis thaliana Col-0 plants at an optical density at 600 nm (OD600) of
0.4 in 5 mM morpholineethanesulfonic acid (MES, pH 5.6) with a needleless
syringe. The production of a hypersensitive response was scored after 48 h.
Yeast two-hybrid interactions. Interactions between proteins were tested with
the pEG202/pJG4-5 yeast two-hybrid system (14). The shcV fragment was cloned
into the vector pJG4-5 with primers P892 and P893, resulting in construct
pLN680. hopPtoV was cloned into pEG202 with primers P894 and P895, making
construct pLN679. hopPtoV DNA fragments corresponding to the N-terminal 97
and 194 amino acids of HopPtoV were cloned into pEG202 with primers P894
and P1086 and primers P894 and P1054, respectively, producing constructs
pLN728 and pLN709, respectively. A hopPtoV DNA fragment corresponding to
the portion of the protein from residue 195 to the C terminus of HopPtoV was
cloned into pEG202 with primers P1055 and P895, resulting in pLN710. Frag-
ments corresponding to internal regions of HopPtoV were cloned into pEG202
with primer pairs P1087 and P1088 (resulting in pLN730), P1089 and P1090
(resulting in pLN765), and P1091 and P1092 (resulting in pLN739). Interaction
analyses were performed in Saccharomyces cerevisiae strain EGY48 (pSH18-34)
by standard protocols (14, 36).
Coimmunoprecipitation experiments with ShcV and HopPtoV. We cloned
shcV by PCR with primers P1047 and P1048 into pQE30 (Qiagen, Valencia,
Calif.), resulting in construct pLN688. This construct produces ShcV fused to six
histidine residues at its amino terminus. For coimmunoprecipitation experi-
ments, we expressed pLN688 and pLN127, which encodes HopPtoV fused to an
HA epitope at its C terminus in E. coli. Briefly, E. coli(pLN127, pLN688)
overnight cultures were used to inoculate 50-ml E. coli cultures at a 1:10 dilution
in LM broth, which were grown to an OD600 of 0.8. Bacterial cultures were
centrifuged, resuspended in 10 ml of TBS (50 mM Tris-HCl, 150 mM NaCl, pH
7.4), and centrifuged again. Cell pellets were resuspended in 10 ml of cold lysis
buffer (20 mM Tris [pH 8.0], 100 mM NaCl) containing lysozyme at 1 mg ml1
and 0.5 mM phenylmethylsulfonyl fluoride and incubated on ice for 10 min.
Cells were sonicated three times for 30 s each, and the cell lysates were centri-
fuged at 12,000 rpm at 4°C. The aqueous phase was transferred to a new tube,
and aliquots were saved separately for analysis.
To immunoprecipitate HopPtoV-HA, a sample of 100 l of anti-HA affinity
matrix (Roche Diagnostics Corp., Indianapolis, Ind.) was added to a sample con-
taining 250 g of total protein in cold lysis buffer. Samples were mixed on a rotary
shaker at 4°C overnight. The affinity matrix was pelleted and washed three times with
cold lysis buffer. The washed matrix was resuspended in 100 l of SDS-PAGE
sample buffer, boiled for 5 min, centrifuged again, and loaded on an SDS-PAGE gel.
After the samples were separated by SDS-PAGE, the proteins were transferred to
polyvinylidene difluoride membranes, and immunoblot analysis was done with an-
ti-HA (Roche Diagnostics Corp.) and anti-His (Qiagen) antibodies to determine
whether His-ShcV coimmunoprecipitated with HopPtoV-HA.
Construction of DC3000 hopPtoV and shcV/hopPtoV mutants. We used a sui-
cide vector, pKnockout-
 (76), to generate insertion mutations in both shcV and
hopPtoV. An internal fragment within the shcV coding region was amplified with
primers P248 and P249 and cloned into pKnockout-
 that had been digested
with XcmI, resulting in construct pLN30. Likewise, an internal fragment within
hopPtoV was PCR amplified with primers P251 and P259 and cloned into XcmI-
TABLE 2. Primers used for plasmid constructions
Primer Nucleotide sequence Enzyme site
P248 5-CTATCTACGGATGTAATC-3
P249 5-AAAATGTGTCGCTGTGTC-3
P251 5-TACTTCACTAATAGCCTG-3
P259 5-GGGAACAGTGCTCGTGTAG-3
P409 5-AGTAGGATCCCAGATATTGCTATCTACG-3 BamHI
P412 5-AGTAAAGCTTGGAAAGAGTATGTTGGAT-3 HindIII
P413 5-AGTATCTAGATCAAGCGTAATCTGGAACATCGTATGGGTACTTTCTATCCGGAATAAC-3 XbaI
P511 5-AGTCTCTAGACTTAGCGGTAGAGCATTG-3 XbaI
P516 5-AGTCACTAGTAGAAAAAGTAGCGCTTCAAG-3 SpeI
P578 5-AGTCAAGCTTCAGATATTGCTATCTACG-3 HindIII
P892 5-AGTGAATTCATGAGCTTATCGCCGACG-3 EcoRI
P893 5-CCGCTCGAGTCAGTTAAAACGAAAATG-3 XhoI
P894 5-ACTGAATTCATGCGGTTTGATGCTGCC-3 EcoRI
P895 5-TATGCGGCCGCTTACTTTCTATCCGGAAT-3 NotI
P1043 5-GATCACTAGTCTTTCTATCCGGAATAAC-3 SpeI
P1047 5-ATAGGATCCAGCTTATCGCCGACGCTG-3 BamHI
P1048 5-GGCCGGTACCGTTAAAACGAAAATGTGT-3 KpnI
P1054 5-TATGCGGCCGCGTGCGGATGTTTTATATG-3 NotI
P1055 5-GCGGAATTCTGGAAAGCCCTGAACGAA-3 EcoRI
P1086 5-AGTCCTCGAGTCATGCTGCCCATACACTGCCTC-3 XhoI
P1087 5-AGTCGAATTCATCAATCTGCAGCATCGCTCG-3 EcoRI
P1088 5-AGTCGTCGACTCAGTGCGGATGTTTTATATGGCGTTC-3 SaII
P1089 5-AGTCGAATTCGTTCGTCCAGAAATGGGTGTAG-3 EcoRI
P1090 5-AGTCGTCGACTCAGTTCCACTGCCCTGCCAC-3 SalI
P1091 5-AGTCGAATTCCGAGTCCGTTTTGCAAGATACCC-3 EcoRI
P1092 5-AGTCGTCGACTCATGGAATATGTGCACCGAAACGC-3 SalI
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digested pKnockout-
, producing construct pLN31. Campbell insertion muta-
tions were made in DC3000 by introducing pLN30 and pLN31 separately into
DC3000 via triparental matings. Because pKnockout-
 cannot replicate in P.
syringae, the majority of DC3000 colonies that became spectinomycin resistant
likely represented shcV or hopPtoV mutants. Putative mutants were confirmed to
have insertions in shcV or hopPtoV by PCR with primers that flanked each gene.
The DC3000 shcV and hopPtoV mutants were designated UNL120 and UNL125,
respectively.
Arabidopsis pathogenicity assays. A. thaliana ecotype Col-0 cells used in patho-
genicity assays were grown in a growth chamber at 23°C with 8 h of light per day.
Disease symptoms and bacterial multiplication in planta were determined by
dip-inoculating plants in P. syringae suspensions adjusted to an OD600 of 0.2 in 10
mM MgCl2 containing 0.02% Silwet L-77 (Lehle Seeds, Round Rock, Tex.).
Bacterial growth was determined as previously described (3). Briefly, 0.3-cm2 leaf
disks were harvested from infected plants on days 0, 2, and 4 postinoculation and
macerated with a mortar and pestle in microcentrifuge tubes. Different dilutions
were spotted on KB plates with the appropriate antibiotics after a 2- to 3-day
incubation period at 30°C and enumerated.
RESULTS
Protein product of ORF6 has the general properties of type
III chaperones. A candidate chaperone-effector pair encoded
by ORF6 and ORF17, respectively, was identified during a
genomewide effector gene search (61). ORF6 and ORF17 are
downstream of a typical type III (Hrp) promoter and within a
pathogenicity island (Pai) that contains the effector genes
hopPtoA2, hopPtoD2, and hopPtoG (Fig. 1) (7, 27, 61). Upon
completion of the annotation of the DC3000 genome, ORF6
and ORF17 were given the names PSPTO4721 and
PSPTO4720, respectively (16).
Generally, we identified candidate chaperone genes based
on their proximity to genes that encode P. syringae TTSS sub-
strates (21, 37, 72). However, we identified ORF17 as a can-
didate effector gene because it was adjacent to ORF6, an ORF
predicted to encode a protein that has many of the character-
istics of TTCs. The product of ORF17 does not possess many
of the general characteristics of P. syringae effectors (39, 61).
For example, there is an aspartate residue at position 4, there
is no isoleucine, leucine, or valine in position 3 or 4, and the
overall serine content in the first 50 residues is low (6%), all
features that would be inconsistent with the export-associated
patterns found in confirmed P. syringae TTSS substrates (39,
61). The lack of export-associated patterns within the ORF17
product is likely to be unrelated to whether it uses a TTC,
because other P. syringae effectors that are dependent on TTCs
have typical export-associated patterns (8, 72).
ORF6 encoded a predicted product that was relatively small
(14.7 kDa), had an acidic pI (6.49), and had a predicted am-
phipathic region in its C-terminal region, which suggested that
it might be a TTC (75). Moreover, with a protein-fold recog-
nition program (3D-PSSM) (50), the ORF6 product showed a
predicted fold similar to that of Salmonella SigE (PSSM E
value, 5.16) and Yersinia SycE (PSSM E value, 12.7), both
TTCs (26, 74).
ORF17 encodes a product that is secreted into culture su-
pernatants via the TTSS, and its secretion is enhanced by
overexpression of ORF6. Because ORF17 was adjacent to a
candidate chaperone gene and within a Pai rich in effector
genes, we wanted to test whether the ORF17 product was
secreted by DC3000 into culture supernatants. To address this,
we PCR cloned ORF17 with nucleotide sequences added to
the 3 primer that encoded an HA affinity tag into pML123,
producing pLN127. This construct was introduced into
DC3000 and a DC3000 hrcC mutant, which is defective in type
III secretion. DC3000(pLN127) secreted a small amount of the
ORF17 protein product into the supernatant fraction (Fig.
2A). To determine whether ORF6 would increase the amount
of the ORF17 product found in culture supernatants, ORF6
and ORF17 were PCR cloned into pML123, resulting in con-
struct pLN517. This construct, which produces the ORF6 and
ORF17 (HA-tagged) products, was electroporated into
DC3000 and the DC3000 hrcC mutant. The amount of ORF17
product found in the DC3000 supernatant fractions increased
dramatically when ORF6 was also present (Fig. 2A), which
clearly showed that ORF17 is a TTSS substrate and that ORF6
likely encoded a TTC. Hereafter, we refer to ORF6 and
ORF17 as ShcV and HopPtoV, respectively.
DC3000 mutant defective in shcV does not secrete detectable
amounts of HopPtoV in culture. To determine how dependent
HopPtoV secretion was on ShcV, two different mutations were
made with a suicide vector called pKnockout-
 (76). shcV and
hopPtoV were interrupted via integration of pKnockout-
,
generating the DC3000 mutants UNL120 and UNL125, re-
spectively. Based on the orientation of pKnockout-
 in the
DC3000 chromosome, UNL120 is predicted to produce a polar
mutation in shcV, and because hopPtoV is likely in the same
operon (Fig. 1), hopPtoV transcription is probably blocked in
UNL120. UNL125 was disrupted within hopPtoV but possessed
an intact shcV gene.
When the hopPtoV mutant UNL125 was transformed with
pLN127 (which carries hopPtoV-ha) or pLN517 (which carries
shcV and hopPtoV-ha), HopPtoV-HA was present in the su-
pernatant fraction of wild-type DC3000 cultures, as expected
FIG. 1. Organization of ORF6 (shcV) and ORF17 (hopPtoV)
within a pathogenicity island in the chromosome of P. syringae pv.
tomato DC3000. ORF6 (shcV), a candidate chaperone gene, and
ORF17 (hopPtoV), its cognate effector gene, are predicted to be part
of the same transcriptional unit and are within a pathogenicity island
containing other type III-related genes. ORF6 and ORF17 are de-
picted as white boxes, and the confirmed effector genes hopPtoA2 (7),
hopPtoD2 (27), and hopPtoG (61) are represented as hatched boxes.
An insertion sequence-interrupted avrPphD gene is depicted as hori-
zontally striped boxes, and the apparent borders of this type III-related
region are delimited by cmaTU and a DNA helicase gene, both rep-
resented as grey boxes. Other ORFs in the region are represented as
stippled boxes. With the exception of ORF6 and ORF17, the numbers
represent the ORF numbers given when the genome was annotated
and should be preceded by the prefix PSPTO. Insertion sequences are
depicted as diagonally striped boxes. The arrow indicates the predicted
direction of ORF6 and ORF17 transcription, and the black box rep-
resent a putative HrpL-dependent (type III) promoter.
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(Fig. 2B). Interestingly, much more HopPtoV-HA was found
in the supernatant fraction of UNL125(pLN127) than was
present in DC3000(pLN127) (Fig. 2), perhaps due to the ab-
sence of native HopPtoV in UNL125, allowing more HopPtoV-
HA (i.e., detectable HopPtoV) to be type III secreted into the
supernatant fraction. Detectable amounts of HopPtoV-HA were
not secreted into supernatant fractions of the DC3000 shcV mu-
tant UNL120(pLN127) (Fig. 2B), which demonstrated the re-
quirement of ShcV for the type III secretion of HopPtoV. How-
ever, when shcV and hopPtoV-ha were provided in trans to
UNL120, HopPtoV-HA was again found in large amounts in the
supernatant fraction (Fig. 2B).
HopPtoV is translocated into plant cells and ShcV is re-
quired for HopPtoV translocation. To determine whether
HopPtoV was a secreted accessory protein or an effector trans-
located into plant cells and, if so, whether ShcV was required
for the translocation of HopPtoV, we used a translocation
assay that tests whether a TTSS substrate is translocated into
plant cells (38, 59). In this assay, a candidate TTSS effector that
possesses potential type III secretion signals is fused to a trun-
cated AvrRpt2 Avr protein lacking its own type III secretion
signals. The truncated AvrRpt2 moiety retains its Avr domain,
which is recognized by Arabidopsis Col-0, resulting in produc-
tion of a hypersensitive response. We made hopPtoV-avrRpt2
fusion constructs with and without the shcV gene and electro-
porated these constructs into P. syringae pv. phaseolicola
NPS3121, which is nonpathogenic on Arabidopsis. NPS3121
carrying pLN702, which encoded HopPtoV-AvrRpt2 alone,
did not elicit a hypersensitive response when infiltrated into
Arabidopsis Col-0 plants, indicating that this fusion protein was
not translocated into plant cells (Fig. 3). In contrast, NPS3121
with pLN703, which encoded ShcV and HopPtoV-AvrRpt2,
did elicit a hypersensitive response on Arabidopsis Col-0 (Fig.
3). These experiments demonstrated that HopPtoV is translo-
cated into plant cells and that the translocation of HopPtoV
into plant cells is dependent on the ShcV TTC.
ShcV type III chaperone interacts with its cognate effector
HopPtoV. To determine whether ShcV binds to HopPtoV, we
made constructs that contained either hopPtoV with a C-ter-
minal HA tag (pLN127) or shcV with an N-terminal six-His tag
(pLN688). These plasmids were transformed together into E.
coli, and this strain was grown to an OD600 of 0.8. The cells
were sonicated, and the soluble proteins were incubated with
anti-HA high-affinity matrix that binds to the HA epitope.
Samples from the total soluble protein, proteins not bound to
the matrix, proteins washed off in the final wash, and proteins
bound to the matrix were separated on SDS-PAGE gels and
FIG. 2. HopPtoV is secreted in culture via the DC3000 TTSS in an
ShcV-dependent manner. (A) Cultures of wild-type (WT) P. syringae
pv. tomato DC3000 and a DC3000 TTSS-defective mutant (hrcC) were
grown in hrp-inducing medium and separated into cell-bound (C) and
supernatant (S) fractions. The cell-bound and supernatant fractions
were concentrated 13.3-fold and 133-fold, respectively, relative to the
initial culture volumes. The samples were separated by SDS-PAGE
and immunoblotted. HopPtoV and -lactamase, which was used as a
lysis control, were detected with anti-HA and anti--lactamase anti-
bodies, respectively. Wild-type DC3000 strains containing plasmid
pLN127 (phopPtoV-ha) or pLN517 (pshcV/hopPtoV-ha) secreted
HopPtoV-HA into the supernatant fraction. However, much more
HopPtoV-HA was found in the supernatant fractions from
DC3000(pLN517), which overexpressed ShcV. (B) Cultures of
DC3000 shcV (UNL120) and hopPtoV (UNL125) insertion mutants
containing plasmid pLN127 (phopPtoV-ha) or pLN517 (pshcV/hopPtoV-
ha) were grown in hrp-inducing medium, separated into cell-bound
(C) and supernatant (S) fractions, and separated by SDS-PAGE. Immu-
noblotted proteins were detected with anti-HA or anti-NPTII antibodies.
Plasmid-encoded NPTII should remain cell bound and was used as a lysis
control. The shcV mutant UNL120 was unable to secrete HopPtoV-HA
unless shcV was also provided in trans.
FIG. 3. AvrRpt2 translocation assays indicate that HopPtoV is
translocated into plant cells in an ShcV-dependent manner. P. syringae
pv. phaseolicola NPS3121 carrying plasmids that encoded either full-
length AvrRpt2, N-terminally truncated AvrRpt2 (AvrRpt2), or a
HopPtoV-truncated AvrRpt2 fusion (HopPtoV-AvrRpt2) with and
without ShcV were infiltrated into A. thaliana Col-0 (RPS2) plants at
an OD600 of 0.4. Plants were scored for production of a hypersensitive
response (HR) after 48 h, and representative leaves were photo-
graphed. Ten leaves were infiltrated for each bacterial strain, and the
number of times that the pictured result was observed over the total
number of samples is indicated as a fraction under each picture.
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analyzed by immunoblotting with antibodies that recognize
either HopPtoV-HA or His-ShcV. As expected, HopPtoV-HA
was detected in the total soluble protein fraction and the ma-
trix fraction (Fig. 4). ShcV was detected weakly in the lysate
fraction and in large amounts in the resin fraction in the pres-
ence of HopPtoV-HA, indicating that ShcV binds to
HopPtoV, which is consistent with ShcV’s acting as a TTC for
HopPtoV (Fig. 4). ShcV did not bind to the anti-HA high-
affinity matrix in the absence of HopPtoV-HA, nor did anti-His
antibodies recognize any proteins similar in size to His-ShcV in
the absence of His-ShcV (Fig. 4), two important controls to
validate the specificity of this interaction. The wash fraction
shown in Fig. 4 represents the last wash before bound proteins
were eluted from the matrix. Thus, our results demonstrate
that His-ShcV and HopPtoV-HA bind to each other, a pre-
requisite for a TTC-effector pair.
ShcV interacts with HopPtoV in yeast two-hybrid assays,
and its binding site is most likely within amino acid residues
76 to 125 of HopPtoV. The secretion, translocation, and coim-
munoprecipitation experiments support the notion that ShcV
acts as a TTC and is needed for the type III secretion and
translocation of HopPtoV. To further delimit the interaction
of ShcV with HopPtoV, we tested the ability of these proteins
to interact in LexA-based yeast two-hybrid interaction assays
(36). The shcV gene was cloned into the activation domain
vector pJG4-5, which created a fusion between ShcV and the
activation domain. The full-length hopPtoV and a series of
hopPtoV gene portions were cloned into the LexA DNA-bind-
ing domain (DBD) vector pEG202, producing protein fusions
with the DBD (Fig. 5A).
Full-length (391 amino acids) DBD-HopPtoV interacted
strongly with AD-ShcV in our yeast two-hybrid experiments, as
indicated by the production of blue pigmentation on galactose-
containing 5-bromo-4-chloro-3-indolyl--D-galactopyranoside
(X-Gal) medium, which activated the pJG4-5 GAL1 promoter
upstream of shcV (Fig. 5B). These proteins also interacted
when they were expressed in the opposite yeast two-hybrid
vector, producing DBD-ShcV and AD-HopPtoV fusion pro-
teins (data not shown). None of the protein fusions produced
any blue pigmentation when they were expressed individually
with vector controls, indicating that they did not activate tran-
scription on their own (data not shown). DBD-HopPtoV195-391,
the C-terminal HopPtoV portion encompassing amino acids 195
to 391, produced white colonies on galactose-containing plates,
indicating that this HopPtoV portion did not contain an ShcV
binding site (Fig. 5B). Yeast cells expressing the fusion protein
containing the N-terminal half of HopPtoV, DBD-HopPtoV1-194,
produced deep blue pigmentation on galactose medium, indicat-
ing that the ShcV binding site is contained within this moiety of
HopPtoV (Fig. 5B). Yeast cells expressing the fusion proteins
DBD-HopPtoV1-97 and DBD-HopPtoV98-194 produced only pale
blue colonies, indicating that they interacted weakly with AD-
ShcV (Fig. 5B).
FIG. 4. HopPtoV interacts with ShcV in coimmunoprecipitation
experiments. Soluble protein samples from sonicated E. coli
DH5(pLN127, pLN688), which expressed HopPtoV-HA and His-
ShcV, were mixed with anti-HA affinity matrix as described in Mate-
rials and Methods. Aliquots from the soluble total protein (lysate), the
protein sample post-anti-HA matrix treatment (unbound), the final
wash, and the proteins bound to the matrix (matrix) were separated by
SDS-PAGE and immunoblotted. HopPtoV-HA and His-ShcV were
detected with anti-HA and anti-His antibodies, respectively. Also in-
cluded were samples that contained constructs that expressed either
ShcV-HA or His-ShcV and a vector control (either pQE30 and
pML123), demonstrating that both proteins needed to be present to
detect His-ShcV in the matrix sample.
FIG. 5. ShcV interacts with the N-terminal third of HopPtoV in
LexA yeast two-hybrid assays, with the strongest binding occurring
between amino acids 76 and 125 of HopPtoV. (A) Schematic repre-
sentation of the HopPtoV fragments that were fused to the DNA-
binding domain (DBD) and used in the LexA yeast two-hybrid inter-
action assay. The top white box represents the full-length HopPtoV
protein (391 amino acids). The lower black bars represent a series of
HopPtoV fragments that were fused to the DBD and tested in the
yeast two-hybrid assay to determine if they interacted with ShcV fused
to the transcriptional activation domain (AD). A representation of the
results is shown: , strong interaction; , no detectable interaction;
/, weak interaction. (B) Yeast strains carrying pJG4-5::shcV (pro-
ducing AD-ShcV) and pEG202 with different hopPtoV fragments (pro-
ducing DBD fusions) were grown at 30°C for 2 days on the appropriate
selective medium containing X-Gal and either galactose (Gal) or glu-
cose (Glu). Results were scored based on the amount of blue pigmen-
tation produced by the colonies: dark blue, strong interaction; pale
blue, weak interaction; and white, no detectable interaction. Analo-
gous experiments measuring the rescue of leucine auxotrophy, the
other reporter of this yeast two-hybrid system, showed similar results
(data not shown).
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Because these fusions combined extend over the region of
HopPtoV that strongly interacted with ShcV, this suggests that
the junction between these two portions is likely to contain the
ShcV binding site. Yeast cells expressing AD-ShcV and either
DBD-HopPtoV76-125 or DBD-HopPtoV51-150 produced blue
colonies nearly as dark as those produced by the fusion DBD-
HopPtoV1-194, supporting the idea that the ShcV binding site
resides within amino acids 76 to 125 of HopPtoV (Fig. 5). In
summary, the ShcV binding site on HopPtoV resides within
the N-terminal 194 amino acids with the strongest binding
occurring within 76 to 125 amino acids of HopPtoV. However,
due to the weak binding of AD-ShcV to DBD-HopPtoV1-97,
we cannot exclude that there may be additional ShcV binding
sites within the first 97 amino acids of HopPtoV.
DC3000 hopPtoV and shcV/hopPtoV mutants show no signif-
icant reduction in disease symptoms or bacterial multiplica-
tion in planta. We were also interested in determining the
importance of HopPtoV in the pathogenic ability of DC3000.
To test this, we dip-inoculated the shcV polar mutant UNL120
and the hopPtoV mutant UNL125 into Arabidopsis Col-0 plants
and surveyed disease symptom production and bacterial
growth in planta over a 4-day period. Both mutants produced
disease symptoms similar to those produced by wild-type
DC3000 (data not shown), and their growth in plant tissue was
not impaired (Fig. 6). Moreover, ectopic overexpression of
shcV and hopPtoV in DC3000 did not enhance bacterial growth
in planta (Fig. 6). Therefore, the contribution of HopPtoV to
virulence in DC3000 does not appear to be significant. How-
ever, the lack of a virulence phenotype can also be explained by
the presence of other effectors in DC3000 with similar activi-
ties.
We also tested whether HopPtoV was an Avr protein on the
plants that we commonly use in our laboratory. To do this, we
PCR cloned hopPtoV into an Agrobacterium binary vector
(pPZP212) and infiltrated Agrobacterium strains carrying this
construct into the leaves of tomato (Lycopersicon esculentum
cv. Moneymaker), Arabidopsis (Col-0), tobacco (Nicotiana
tabacum cv. Xanthi), and Nicotiana benthamiana. None of the
infiltrated leaves showed a hypersensitive response (data not
shown). This indicates that these plants do not have innate
immune systems that can recognize HopPtoV. However, it
remains a possibility that HopPtoV acts as an Avr protein on
other plants.
DISCUSSION
This report describes experiments that show that HopPtoV
is a type III effector that is secreted in culture (Fig. 2) and
translocated (Fig. 3) into plant cells by the P. syringae pv.
tomato DC3000 TTSS. Both the type III secretion and trans-
location of HopPtoV are dependent on ShcV (Fig. 2 and 3), a
protein that possess the general characteristics of a TTC. As
part of a larger survey study, HopPtoV was recently shown to
be translocated into plant cells with a different translocation
assay than we described here (66). However, this report did not
demonstrate that HopPtoV translocation was dependent on
ShcV. ShcV binds directly to HopPtoV, based on immunopre-
cipitation and yeast two-hybrid experiments (Fig. 4 and 5), and
the binding site is within the amino-terminal third of HopPtoV,
with the strongest binding occurring between residues 76 and
125 of the 391-amino-acid-long HopPtoV (Fig. 5). We found
that DC3000 hopPtoV mutants were not significantly impaired
in either disease symptom production or bacterial growth in
planta (Fig. 6). However, given the number of type III effectors
present in DC3000 and their apparently functionally redun-
dant roles, this result does not mean that HopPtoV is unim-
portant for plant pathogenesis. In fact, the number of P. syrin-
gae effector mutants that show a reduction in symptom
production and growth in plant tissue is limited to only a few
effectors, illustrating why the large inventory of P. syringae
effectors were not isolated in genetic screens assessing viru-
lence reduction (55, 62).
The identification of ShcV as a TTC brings the total number
of demonstrated bacterial plant pathogen TTCs to four: ShcA
(72), DspB/F (35), ShcM (8), and ShcV. DspB/F is from Er-
winia amylovora CFPB1430, and ShcA is from P. syringae pv.
syringae 61, while ShcM and ShcV are both from DC3000.
When we identified ShcA as a TTC, we performed a search of
the nucleotide databases to identify other putative TTC genes
adjacent to P. syringae effector and avr genes and identified
several additional candidate P. syringae TTCs (72). The avail-
ability of the entire DC3000 genome sequence and the iden-
tification of many confirmed and predicted DC3000 TTSS sub-
strates provided an opportunity to identify TTC genes in
DC3000. We searched the adjacent regions of the confirmed
and predicted TTSS substrates described by Collmer et al. (21)
and found nine TTCs and candidate TTCs in DC3000, which
are listed in Table 3. Several of the candidates on this list likely
represent functional TTCs. For example, ShcAPto is a homolog
FIG. 6. ShcV and HopPtoV do not contribute measurably to the
ability of DC3000 to grow in Arabidopsis leaf tissue. The following
strains were dip inoculated into A. thaliana Col-0 as described in
Materials and Methods: wild-type DC3000 (WT); wild-type DC3000
with the empty vector pML123; DC3000(pLN517) expressing shcV and
hopPtoV; the DC3000 shcV mutant UNL120; and the DC3000 hopPtoV
mutant UNL125. Leaf tissue was harvested at days 0, 2, and 4 and
enumerated by plating dilutions on KB plates with the appropriate
antibiotics. Each assay was done at least three times, and error bars
indicate standard deviations. These results suggest that ShcV and
HopPtoV do not contribute significantly to growth in planta. The
disease symptoms produced by these strains were similar (data not
shown).
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of ShcA (72), PSPTO1376 (also referred to as AvrF) and AvrE
are homologs of DspB/F and DspA/E, respectively, a chaper-
one-effector pair from Erwinia amylovora (12, 35), and
PSPTO0503 and HopPtoF are homologs of AvrPphF ORF1
and ORF2, respectively, both of which are required for AvrP-
phF-induced defense responses, suggesting that AvrPphF
ORF1 encodes a TTC (61, 70).
TTCs from animal pathogens belong to two main classes (22,
60). Class I consists of chaperones that bind to effectors, and
these are separated further if they interact with only one ef-
fector (class IA) or multiple effectors (class IB). Class II chap-
erones assist in the secretion of translocators, which are se-
creted proteins that form pores in the eukaryotic plasma
membrane that allow effector delivery. The TTCs that function
in the evolutionarily related flagellum biogenesis system ap-
pear to constitute a separate class (class III) (9). The DC3000
chaperones (and candidates) listed in Table 3 are likely to be
class I chaperones because the TTSS substrates that utilize
them are effectors instead of translocators. Translocators in
bacterial plant pathogen TTSSs have yet to be well character-
ized. However, the putative translocators HrpZ from P. syrin-
gae and HrpF from Xanthomonas campestris pv. vesicatoria do
not appear to require TTCs for their secretion (2, 17, 42, 54,
63).
The confirmed DC3000 chaperones ShcA, ShcM, and ShcV
have several similarities and some differences with each other
and with animal-pathogen TTCs. For example, there is no
indication that ShcA, ShcM, or ShcV stabilizes it cognate ef-
fector. However, only in the case of ShcA were the experi-
ments carried out with natively expressed effector (72). In
experiments with ShcM (8) and ShcV (Fig. 2), the effector was
overexpressed from multicopy plasmids, which may mask a
reliance on the chaperone for effector stability. The majority of
animal-pathogen TTCs stabilize their cognate effectors (29,
60), as does the E. amylovora DspB/F TTC (35). The instability
of effectors may be due to aggregation-prone domains present
in the effectors, as was shown for the Yersinia YopE effector,
which possesses an aggregation domain that is masked by the
SycE TTC (13, 30). We are currently testing whether DC3000
effectors possess domains that cause interactions with other
proteins that might interfere with their type III secretion in the
absence of a TTC.
An interesting difference between the DC3000 TTCs is that
while the secretion of P. syringae pv. syringae HopPsyA is
dependent on the ShcA TTC, when hopPsyA is provided in
trans the overexpression of HopPsyA overrides the need for
ShcA (72). This is in contrast to the DC3000 effectors Hop
PtoM and HopPtoV, which are dependent on their TTCs even
when they are overexpressed (8) (Fig. 2). In practice, this may
indicate that HopPtoM and HopPtoV would be better proteins
than HopPsyA with which to elucidate chaperone-associated
domains. However, it may also provide an important clue to
why certain effectors require TTCs while many others appar-
ently do not. For example, perhaps HopPtoM and HopPtoV
interact more strongly with cytosolic proteins than HopPsyA,
blocking their secretion more stringently. Alternatively, the
secretion signals for HopPtoM and HopPtoV may not be avail-
able for recognition by the type III apparatus unless a chaper-
one is bound. Indeed, the similarities of the protein structures
of the SicP-SptP and SycE-YopE chaperone-effector com-
plexes in the absence of sequence similarity make the hypoth-
esis that the bound TTC acts as part of a type III secretion
signal an attractive one (11, 68).
Given the prevalence of TTCs in TTSS-containing organ-
isms and the extent to which animal-pathogen TTCs have been
studied, a reasonable question to ask is what can be learned
from studying bacterial plant pathogen TTCs. Even though
significant advances have been made on TTCs from animal
pathogens, it is still not known how they facilitate the secretion
of TTSS substrates. Isolating and studying TTCs from more
distantly related TTSSs such as plant pathogens should provide
insight into their activities. A recent phylogenetic analysis of
TTSSs places the TTSS of P. syringae in a different group from
animal-pathogen TTSSs (31). Initial reports of plant-pathogen
TTCs do indicate they may have different properties than their
animal-pathogen counterparts.
Another practical reason to catalog the DC3000 effectors
that require TTCs is the possibility that effectors that utilize
TTCs are the first ones to be translocated into host cells and
are important for early events in pathogenesis. Several recent
papers provide evidence that TTCs may help set up a hierarchy
for TTSS substrates to gain access to the type III apparatus,
either by helping their cognate effectors compete for the type
III secretion machinery (13), by their involvement in regulation
of the TTSS through feedback regulation (18, 19, 33, 77), or by
acting as coactivators (25, 58). Moreover, the Yersinia effectors
that require TTCs, YopE, YopH, and YopT, play antiphago-
cytic roles that are required early during the infection process
(29). Thus, DC3000 effectors that utilize chaperones may play
important early roles in plant-bacterium interactions. The
identification of these effectors, their TTCs, and the mecha-
TABLE 3. Confirmed and predicted type III chaperones from P. syringae pv. tomato DC3000
Chaperone or
ORF Size (kDa) pI
Effector or
ORF Accession no. Reference(s)
ShcAPto 14.4 5.3 HopPsyAPto AE016875 16, 72
ShcM 18.0 5.3 HopPtoM AE016860 8, 72
ShcV 14.7 6.5 HopPtoV AAO58159 This work, 16
PSPTO0503 15.6 6.1 HopPtoF AE016857 16, 70
PSPTO1369 19.9 6.8 HopPtoN AF232006 3, 72
PSPTO1376 14.6 5.3 AvrE AF232006 3, 72
PSPTOA0017 15.6 5.5 HopPtoS1 AE016855 16, 39, 61
PSPTO4589 17.1 5.9 PSPTO4588 AE016872 16
PSPTO4599 17.2 5.3 PSPTO4597 AE016872 16
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nisms used for their delivery will provide a more complete
picture of plant pathogenesis by P. syringae.
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